title: Membranous glomerulonephritis in a patient with Hodgkin's lymphoma in remission.
authors.forename: María
authors.initials: M
authors.lastname: Sánchez
authors.forename: Ricardo
authors.initials: R
authors.lastname: Enríquez
authors.forename: Ana E
authors.initials: AE
authors.lastname: Sirvent
authors.forename: Laura
authors.initials: L
authors.lastname: Heredia
authors.forename: Isabel
authors.initials: I
authors.lastname: Millán
authors.forename: Francisco
authors.initials: F
authors.lastname: Amorós
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000532:radiotherapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D012074:Remission Induction; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D007166:Immunosuppressive Agents; D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D011241:Prednisone; D016559:Tacrolimus